Literature DB >> 1090976

Ultrasonographic determination of the splenic size and its clinical usefulness in various liver diseases.

T Koga, Y Morikawa.   

Abstract

Contact ultrasonic tomography was employed to obtain the size of the spleen in vivo. The scanning was done parallel to the ribs, and the splenotomograms obtained by this method showed three basic patterns of enlargement: a soft, bulging spleen, splenic congestion, or a firm spleen. Of the 96 patients with liver disease studied by this technique, 95% gave evidence of splenic enlargement. Useful information on prognosis may be obtained by observing the changes in the sectional areas of the spleen.

Entities:  

Mesh：

Year:  1975        PMID： 1090976     DOI： 10.1148/115.1.157

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  10 in total

1.  Automated segmentation and quantification of liver and spleen from CT images using normalized probabilistic atlases and enhancement estimation.

Authors:  Marius George Linguraru; Jesse K Sandberg; Zhixi Li; Furhawn Shah; Ronald M Summers
Journal:  Med Phys       Date:  2010-02       Impact factor: 4.071

2.  Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography.

Authors:  Yoshihiro Furuichi; Fuminori Moriyasu; Junichi Taira; Katsutoshi Sugimoto; Takatomo Sano; Shigeki Ichimura; Yuki Miyata; Yasuharu Imai
Journal:  J Gastroenterol       Date:  2012-11-10       Impact factor: 7.527

3.  Sonographic biometry of liver and spleen size in childhood.

Authors:  M Dittrich; S Milde; E Dinkel; W Baumann; D Weitzel
Journal:  Pediatr Radiol       Date:  1983

4.  Assessing splenomegaly: automated volumetric analysis of the spleen.

Authors:  Marius George Linguraru; Jesse K Sandberg; Elizabeth C Jones; Ronald M Summers
Journal:  Acad Radiol       Date:  2013-03-25       Impact factor: 3.173

5.  Examiner dependence on physical diagnostic tests for the detection of splenomegaly: a prospective study with multiple observers.

Authors:  S G Tamayo; L S Rickman; W C Mathews; S C Fullerton; A E Bartok; J T Warner; D W Feigal; D G Arnstein; N S Callandar; K D Lyche
Journal:  J Gen Intern Med       Date:  1993-02       Impact factor: 5.128

6.  An approach for assessment of tumor volume from mammography in locally advanced breast cancer.

Authors:  Gupreet Singh; Sanjay Thulkar; Ashu Seith; Rajinder Parshad; Pratik Kumar
Journal:  Malays J Med Sci       Date:  2008-01

7.  No differences in splenic emptying during on-transient supine cycling between aerobically trained and untrained participants.

Authors:  Damir Zubac; Ante Obad; Daniela Šupe-Domić; Ana Bošnjak; Mirela Zec; Vladimir Ivančev; Zoran Valić
Journal:  Eur J Appl Physiol       Date:  2022-01-11       Impact factor: 3.346

8.  Point-of-care ultrasonography improves the diagnosis of splenomegaly in hospitalized patients.

Authors:  Andrew P J Olson; Bernard Trappey; Michael Wagner; Michael Newman; L James Nixon; Daniel Schnobrich
Journal:  Crit Ultrasound J       Date:  2015-09-17

9.  Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy.

Authors:  Shu Wen Wen; Sarah J Everitt; Justin Bedő; Marine Chabrot; David L Ball; Benjamin Solomon; Michael MacManus; Rodney J Hicks; Andreas Möller; Antoine Leimgruber
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

10.  Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures.

Authors:  Yuno Nishida; Tomokazu Kawaoka; Michio Imamura; Maiko Namba; Yasutoshi Fujii; Shinsuke Uchikawa; Kazuki Ohya; Kana Daijo; Yuji Teraoka; Kei Morio; Hatsue Fujino; Takashi Nakahara; Masami Yamauchi; Akira Hiramatsu; Masataka Tsuge; Hiroshi Aikata; Shoichi Takahashi; C Nelson Hayes; Takayuki Fukuhara; Keiji Tsuji; Keiko Arataki; Yuko Nagaoki; Yasuyuki Aisaka; Koji Kamada; Hideaki Kodama; Kazuaki Chayama
Journal:  Intern Med       Date:  2020-10-21       Impact factor: 1.271
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.